Craft

Revvity

Stock Price

$106.9

2024-06-24

Market Capitalization

$13.2 B

2024-06-24

Revenue

$2.8 B

FY, 2023

Revvity Summary

Company Summary

Overview
Revvity (formerly PerkinElmer) is a company that provides health science solutions, technologies, expertise, and services. It offers research and development (R&D) services such as genomic analysis, research, clinical testing, diagnostics, etc. The company also provides automation solutions for sample preparation and drug discovery, radiometric detection, imaging, and other applications. Revvity also develops signals software for R&D automation and collaboration.
Type
Public
Status
Active
Founded
1937
HQ
Waltham, MA, US | view all locations
Website
https://www.revvity.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Prahlad Singh

    Prahlad Singh, President and Chief Executive Officer, Director

  • Max Krakowiak

    Max Krakowiak, Senior Vice President and Chief Financial Officer

  • Jayashree Thacker

    Jayashree Thacker, Senior Vice President, Global Chief Information Officer

  • Magali Four

    Magali Four, Senior Vice President, Chief People and Culture Officer

Operating MetricsView all

Countries (Sales and Service)

190

FY, 2022

Countries (Sales Representatives)

40

FY, 2022

Sales Representatives

6.3K
3.1%

FY, 2022

LocationsView all

26 locations detected

  • Waltham, MA HQ

    United States

    940 Winter St

  • Melbourne, VIC

    Australia

    Building C, Level 2, Tenancy A 211 Wellington Road

  • Lier, Vlaams Gewest

    Belgium

    Duwijcklaan 17

  • São Paulo, SP

    Brazil

    Rua Samaritá, 1117 - Jardim das Laranjeiras

  • Mississauga, ON

    Canada

    2566 Meadowpine Blvd

  • Shanghai, Shanghai Shi

    China

    No.1670 Zhangheng Road

and 20 others

Revvity Financials

Summary Financials

Revenue (Q1, 2024)
$649.9M
Gross profit (Q1, 2024)
$355.0M
Net income (Q1, 2024)
$26.0M
Cash (Q1, 2024)
$998.1M
EBIT (Q1, 2024)
$44.1M
Enterprise value
$16.1B

Footer menu